The North Shore-LIJ Departments of Urology and Interventional Radiology have initiated a groundbreaking cooperative program for the diagnosis and treatment of prostate cancer -- the most common cancer in men worldwide.
In the past, prostate cancer was diagnosed using “blind” or random biopsies performed with transrectal ultrasound guidance to ensure that the biopsy was being obtained from the prostate gland. However, over the past several years, magnetic resonance imaging (MRI) has been shown to be a valuable tool to aid in the screening and diagnosis of prostate cancer. The information from the MRI can guide our clinicians to specific areas of the prostate. Dr. Rastinehad leads the prostate cancer imaging program which analyzes the MRI information and when necessary performs a biopsy of the cancer by targeting those specific abnormalities seen on the scan.
Once a diagnosis of prostate cancer has been made, the urologists of North Shore-LIJ’s Arthur Smith Institute will advise patients on the appropriate course of therapy. Imaging surveillance, drug or hormonal therapy, radiation therapy and/or surgery might be recommended, based on the patient’s needs.
The imaging experience of our radiologists combined with the clinical expertise of our urologists enables us to deliver the most appropriate and most innovative prostate cancer care to our patients.
For more information on prostate cancer care at North Shore-LIJ Health System, call (516) 734-8500, or visit The Arthur Smith Institute for Urology.
To schedule a prostate MRI, please call 516-734-8600.